Decitabine for Acute Myeloid Leukaemia in Children

• Research type

  Research Study

• Full title

  Phase 1-2 Safety and Efficacy Study of DACOGEN (decitabine) in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia

• IRAS ID

  131833

• Contact name

  Pamela Kearns

• Contact email

  p.r.kearns@bham.ac.uk

• Sponsor organisation

  Janssen-Cilag International NV

• Eudract number

  2013-000390-70

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  13/WM/0232

• Date of REC Opinion

  26 Jul 2013

• REC opinion

  Further Information Favourable Opinion